References
- Gilston V., Blake D.R., Winyard P.G. The rheumatoid joint: redox-paradox?. Oxidative Stress in Cancer, AIDS, and Neurodegenerative Diseases, L. Montagnier, R. Olivier, C. Pasquier. Marcel Dekker, New York 1998; 517–535, In
- Karin M., Ben_Neriah Y. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annual Review of Immunology 2000; 18: 621–663
- Schreck R., Rieber P., Baeuerle P.A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO Journal 1991; 10: 2247–2258
- Los M., Droge W., Sticker K., Baeuerle P.A., Schulze-Osthoff K. Hydrogen peroxide as a potent activator of T lymphocyte functions. European Journal of Immunology 1995; 25: 159–165
- Droge W., Schulze-Osthoff K., Mihm S., Galter D., Schenk H., Eck H.P., Roth S., Gmunder H. Functions of glutathione and glutathione disulphide in immunology and immunopathology. FASEB Journal 1994; 8: 1131–1138
- Schulze-Osthoff K., Baeuerle P.A. Redox signalling by transcription factors NF-κB and AP-1 in lymphocytes. Advances in Cell and Molecular Biology 1995; 50: 735–741
- Israel N., Gougerot-Pocidalo M.A., Aillet F., Virelizer J.L.J. Redox status of cells influences constitutive or induced NF-κB translocation and HIV long terminal repeat activity in human T and monocytic cell lines. Immunology 1992; 149: 3386–3393
- Anderson M.T., Staal F.J., Gitler C., Herzenberg L.A. Separation of oxidant-initiated and redox-regulated steps in the NF-kappa B signal transduction pathway. Proceedings of the National Academy of Sciences, USA 1994; 91: 11527–11531
- Los M., Schenk H., Hexel K., Baeuerle P.A., Droge W., Schulze-Osthoff K. IL-2 gene expression and NF-κB activation through CD28 requires reactive oxygen production by 5-lipoxygenase. EMBO Journal 1995; 14: 3731–3740
- Meyer M.R., Schreck R., Baeuerle P.A. Hydrogen peroxide and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO Journal 1993; 12: 2005–2015
- Peng M., Huang L., Xie Z.-J., Huand W.-H., Askari A. Oxidant-induced activation of nuclear factorkappa B and activator protein-1 in cardiac myocytes. Cellular and Molecular Biology Research 1995; 41: 189–197
- Kaul N., Forman H.J. Activation of NF-kappa B by the respiratory burst of macrophages. Free Radical Biology and Medicine 1996; 21: 401–405
- Milligan S.A., Owens M.W., Grisham M.B. Differential regulation of extracellular signal-regulated kinase and nuclear factor-κB signal transduction pathways by hydrogen peroxide and tumour necrosis factor. Archives of Biochemistry and Biophysics 1998; 352: 255–262
- Adcock I., Brown C.R., Kwon O., Barnes P.J. Oxidative stress induces NF-kappa B DNA binding and inducible NOS mRNA in human epithelial cells. Biochemical and Biophysical Research Communications 1994; 199: 1518–1524
- Satriano J., Schlondorff D. Activation and attenuation of transcription factor NF-κB in mouse glomerular mesangial cells in response to tumournecrosis-factor-alpha, immunoglobulin G, and adenosine 3′/5′-cyclic monophosphate—evidence for involvement of reactive oxygen species. Journal of Clinical Investigation 1994; 94: 1629–1636
- Brennan P., O'Neill L.A.J. Effects of oxidants and anti-oxidants on nuclear factor (B activation in three different cell lines: evidence against a universal hypothesis involving oxygen radicals. Biochimica et Biophysica Acta 1995; 1260: 167–175
- Kazmi S.M.I., Plante R.K., Visconti V., Taylor G.R., Zhou L., Lau C.Y.J. Suppression of NF-κB activation and NF-κB-dependent gene expression by tepoxalin, a dual inhibitor of cyclooxygenase and 5-lipoxygenase. Cellular Biochemistry 1995; 57: 299–310
- Ginn-Pease M.E., Whisler R.L. Redoxsignals and NF-κB activation in T cells. Free Radical Biology and Medicine 1998; 25: 346–361
- Bonizzi G., Piette J., Merville M.-P., Bours V. Function and activation of NF-κB in the immune system. Biochemical Pharmacology 2000; 59: 7–11
- Schreck R., Meier B., Mannel D.N., Droge W., Baeuerle P.A. Modulation of transcription factor NF-κB activity by intracellular glutathione levels and by variations of the extracellular cysteine supply. Journal of Experimental Medicine 1992; 175: 1181–1194
- Fujisawa K., Aono H., Hasunuma T., Yamamoto K., Mita S., Nishioka K. Activation of transcription factor NF-κB in human synovial cells in response to tumour necrosis factor α. Arthritis and Rheumatism 1996; 39: 197–203
- Verhasselt V., Vanden Berghe W., Vanderheyde N., Willems F., Haegeman G., Goldman M.J. N-acetyl-l-cysteine inhibits primary human T cell responses at the dendritic cell level: association with NF-κB inhibition. Immunology 1999; 162: 2569–2574
- Piret B., Bonizzi G., Merville M.-P., Bours V., Piette J. NF-κB transcription factor activation: importance of the redox regulation. Oxidative Stress in Cancer, AIDS, and Neurodegenerative Diseases, L. Montagnier, R. Olivier, C. Pasquier. Marcel Dekker, New York 1998; 63–74, In
- Bowie A., O'Neill L.A.J. Oxidative stress and nuclear factor-κB activation. A reassessment of the evidence in the light of recent discoveries. Biochemical Pharmacology 2000; 59: 13–23
- Li N., Karin M. Is NF-κB the sensor of oxidative stress?. FASEB Journal 1999; 13: 1137–1143
- Staal F.J.T., Anderson M.T., Herzenberg L.A. Intracellular thiols regulate activation of NF-κB and transcription of human immunodeficiency virus. Methods in Enzymology 1995; 252: 168–174
- Schreck R., Albermann K., Baeuerle P.A. Nuclear factor κB. An oxidative stress-responsive transcription factor of eukaryotic cells (a review). Free Radical Research 1992; 17: 221–237
- Sen C.K., Roy S., Packer L. Involvement of intracellular Ca2+ in oxidant-induced NF-κB activation. FEBS Letters 1996; 385: 58–62
- Suzuki Y.J., Mizuno M., Packer L.J. Signal transduction for nuclear factor-κB activation. proposed location of the antioxidant-inhibitable step. Immunology 1994; 153: 5008–5015
- Pyatt D.W., Grutmeir J., Stillman W.S., Irons R.D. Dimethyldithiocarbamate inhibits in vitro activation of primary human CD4+ T lymphocytes. Toxicology 1998; 128: 83–90
- Brennan P., O'Neill L.A. 2-Mercaptoethanol restores the ability of nuclear factor kappa B (NF kappa B) to bind DNA in nuclear extracts from interleukin-l-treated cells incubated with pyrolidine dithiocarbamate (PDTC). Evidence for oxidation of glutathione in the mechanism of inhibition of NF kappa B by PDTC. Biochemical Journal 1996; 329: 975–981
- Moellering D., McAndrew J., Jo H., Darley-Usmar V.M. Effects of pyrrolidine dithiocarbamate on endothelial cells: protection against oxidative stress. Free Radical Biology and Medicine 1999; 26: 1138–1145